Dr. Prakhar Vijayvargiya, MD

Dr. Vijayvargiya practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Vijayvargiya's NPI, 1356781967, was assigned on June 27, 2013. Dr. Vijayvargiya holds Mississippi license 27590.

Dr. Vijayvargiya's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Dr. Vijayvargiya's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Vijayvargiya to 1 more behavioral health center, named with a free account. Dr. Vijayvargiya's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vijayvargiya practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Vijayvargiya's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Vijayvargiya's licenses on file in 2 states: Mississippi and Florida.

CMS data shows 506 Medicare services from Dr. Vijayvargiya across 4 procedure codes in 2024, for 164 Medicare patients. Medicare paid $48,270 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Vijayvargiya in 2024. The largest group is under 65, with 81 patients. 75% of them have high blood pressure, and 74% have chronic kidney disease. 43% are also on Medicaid. Their average risk score is 4.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vijayvargiya's median patient age at 57, with 46% women.

In 2024, Dr. Vijayvargiya wrote 101 Medicare Part D claims for 33 patients. 70% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $61,113 in total drug cost. In 2023, CMS named 65 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Vijayvargiya for performance year 2024, reported as part of a group. Dr. Vijayvargiya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Vijayvargiya, published from 2018 to 2025. 2020 was the busiest year, with 7. The most frequent topics are COVID-19, Anti-Bacterial Agents and Antifungal Agents. Dr. Vijayvargiya has published most often in Open Forum Infect Dis. Dr. Vijayvargiya's most frequent co-authors are Zerelda Esquer Garrigos, MD, Larry M. Baddour, MD and Muhammad Rizwan Sohail, MD.

CMS Open Payments shows 12 general payments to Dr. Vijayvargiya from 3 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $186.